| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99205 |
Prolong outpt/office vis |
2,160 |
2,125 |
$285K |
| 99215 |
Prolong outpt/office vis |
1,736 |
1,622 |
$187K |
| 99385 |
|
1,134 |
1,120 |
$110K |
| 99386 |
|
696 |
686 |
$78K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
344 |
311 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
152 |
$7K |
| 94760 |
|
2,369 |
2,014 |
$5K |
| 86580 |
|
393 |
385 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
28 |
$3K |
| 80305 |
|
111 |
110 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
13 |
$790.72 |
| 81003 |
|
78 |
77 |
$90.00 |
| 96127 |
|
18 |
18 |
$67.84 |
| 81002 |
|
19 |
19 |
$59.47 |
| 2010F |
|
3,473 |
3,088 |
$0.00 |
| 2001F |
|
1,303 |
1,246 |
$0.00 |
| 3008F |
|
466 |
436 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
67 |
62 |
$0.00 |
| G0429 |
Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy) |
42 |
42 |
$0.00 |
| 99406 |
|
69 |
63 |
$0.00 |
| 3288F |
|
189 |
182 |
$0.00 |
| 99483 |
Prolong outpt/office vis |
18 |
16 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
35 |
31 |
$0.00 |